Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Ioscan
Amidotrizoic acid dihydrate 378.65mg/mL
Oral solution
Regional Health Limited
Surch Australia, Sydney, Australia
Tismor Health and Wellness Pty Limited, Sydney, Australia
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Penthrox
Methoxyflurane 99.9%w/w
Volatile liquid for inhalation
Douglas Pharmaceuticals Limited
Medical Developments International Limited, Melbourne, Australia
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Revolade
Eltrombopag olamine 31.9mg equivalent to eltrombopag 25mg
Film coated tablet
Novartis New Zealand Limited
Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations), Ware,
United Kingdom
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Revolade
Eltrombopag olamine 63.8mg equivalent to eltrombopag 50mg
Film coated tablet
Novartis New Zealand Limited
Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations), Ware,
United Kingdom
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Revolade
Eltrombopag olamine 95.7mg equivalent to eltrombopag 75mg
Film coated tablet
Novartis New Zealand Limited
Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations), Ware,
United Kingdom
|
Dated this 14th day of October 2016.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz